Novel Pyrroloquinoline Quinone-Modified Cerium Oxide Nanoparticles and Their Selective Cytotoxicity Under X-Ray Irradiation.

Ionizing radiation leads to the development of oxidative stress and damage to biologically important macromolecules (DNA, mitochondria, etc.), which in turn lead to cell death. In the case of radiotherapy, both cancer cells and normal cells are damaged.

Novel Flavin Mononucleotide-Functionalized Cerium Fluoride Nanoparticles for Selective Enhanced X-Ray-Induced Photodynamic Therapy.

X-ray-induced photodynamic therapy (X-PDT) represents a promising new method of cancer treatment. A novel type of nanoscintillator based on cerium fluoride (CeF) nanoparticles (NPs) modified with flavin mononucleotide (FMN) has been proposed. A method for synthesizing CeF-FMN NPs has been developed, enabling the production of colloidal, spherical NPs with an approximate diameter of 100 nm, low polydispersity, and a high fluorescence quantum yield of 0.

Using Spent Brewer's Yeast to Encapsulate and Enhance the Bioavailability of Sonochemically Nanostructured Curcumin.

This study is aimed at investigating the possibility of using spent cells of brewer's yeast to encapsulate the plant antioxidant curcumin and the effect of such an approach on the bioavailability of BAS in an digestion model. Spent brewer's yeast is a significant volume organic waste that is difficult to dispose of, which makes additional options for its use very promising. Encapsulation of curcumin into spent yeast cells was carried out in a nanostructured manner.

[The relationship of exudative age-related macular degeneration with lacrimal fluid chemokines in elderly patients.].

Age-related macular degeneration (AMD), along with other age-associated ophthalmologies, is a significant cause of loss of visual functions among the elderly, but the relationship of exudative AMD with lacrimal fluid chemokines has not been sufficiently studied. The aim of the work was to study the relationship of exudative AMD with lacrimal fluid chemokines in elderly patients. The content of chemokines in the lacrimal fluid was studied in 92 patients (184 eyes) 60-74 years old with exudative AMD and 84 patients (168 eyes) 60-74 years old without ophthalmopathology using a certified MAGRIX (USA) immunoassay device with Luminex technology on the xMAX platform.